Endocrinology Advisor3d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
BioSpace6d
Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
Medscape5d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
Merilog is approved as both a 3 mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. Like Novolog, Merilog should be given subcutaneously within 5-10 minutes prior to the start of a ...
Monthly Prescribing Reference5d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin ... use prefilled pen; the prefilled pen dials in 1-unit increments.